PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin...

120

Transcript of PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin...

Page 1: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 2: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 3: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 4: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 5: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 6: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 7: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 8: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 9: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 10: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 11: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 12: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 13: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 14: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 15: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 16: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 17: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 18: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 19: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 20: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 21: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 22: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 23: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 24: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 25: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 26: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 27: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 28: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 29: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 30: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 31: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 32: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 33: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 34: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 35: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 36: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 37: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 38: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 39: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 40: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 41: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 42: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 43: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 44: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 45: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 46: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 47: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 48: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 49: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 50: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 51: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 52: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 53: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 54: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 55: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 56: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 57: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 58: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 59: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 60: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 61: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 62: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 63: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 64: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 65: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 66: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 67: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 68: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 69: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 70: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 71: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 72: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 73: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 74: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 75: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 76: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 77: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 78: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 79: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 80: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 81: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 82: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 83: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 84: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 85: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 86: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 87: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 88: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 89: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 90: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 91: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 92: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 93: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 94: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 95: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 96: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 97: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 98: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 99: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 100: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 101: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 102: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 103: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 104: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 105: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 106: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 107: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 108: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 109: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 110: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 111: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 112: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,

ONSCREEN BACK-UP SLIDES

Page 113: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 114: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 115: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 116: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 117: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 118: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 119: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,
Page 120: PowerPoint Presentation · PDF file133 100 Exe: exenatide extended release; IGlar: insulin glargine; PBO: placebo; Serna: semaglutide; ... FAS, on-treatment without rescue medication,

Archiving SAP Data—Practical Guide - Amazon S3 · PDF file133 Chapter 3 Like for data storage, you have many selection options available for accessing archived data. Depending on

Archiving SAP Data—Practical Guide - Amazon S3 · PDF file133 Chapter 3 Like for data storage, you have many selection options available for accessing archived data. Depending on

semaglutide 0.25mg, 0.5mg and 1mg solution for injection ...€¦ · Novo Nordisk Ltd. 9 November 2018 (Issued 7 December 2018) The Scottish Medicines Consortium (SMC) has completed

semaglutide 0.25mg, 0.5mg and 1mg solution for injection ...€¦ · Novo Nordisk Ltd. 9 November 2018 (Issued 7 December 2018) The Scottish Medicines Consortium (SMC) has completed

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … › content › dam › Canada › AFFILIATE › ... · 2 days ago · RYBELSUS® (semaglutide tablets) Product Monograph Page 1

PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION … › content › dam › Canada › AFFILIATE › ... · 2 days ago · RYBELSUS® (semaglutide tablets) Product Monograph Page 1

Australian public assessment report for Semaglutide

Australian public assessment report for Semaglutide

Does intervention with GLP-1 receptor agonist semaglutide … · 2021. 7. 19. · STUDY PROTOCOL Open Access Does intervention with GLP-1 receptor agonist semaglutide modulate perception

Does intervention with GLP-1 receptor agonist semaglutide … · 2021. 7. 19. · STUDY PROTOCOL Open Access Does intervention with GLP-1 receptor agonist semaglutide modulate perception

Advances in GLP-1 treatment: focus on oral semaglutide

Advances in GLP-1 treatment: focus on oral semaglutide

Personal · PDF file133 Sample ESSAYS (Set 3) Personal Statement Secrets not have the complete set of tools to do other procedures. I continued to assist my aunt by calling in

Personal · PDF file133 Sample ESSAYS (Set 3) Personal Statement Secrets not have the complete set of tools to do other procedures. I continued to assist my aunt by calling in

Completion of the 4 Accounting Cycle - John Wiley & · PDF file133 Completion of the Accounting Cycle Before studying this chapter, you should know or, if necessary, review: How to

Completion of the 4 Accounting Cycle - John Wiley & · PDF file133 Completion of the Accounting Cycle Before studying this chapter, you should know or, if necessary, review: How to

The GLP-1 Analogs Liraglutide and Semaglutide Reduce ... · The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE / and LDLr / Mice by a Mechanism That Includes

The GLP-1 Analogs Liraglutide and Semaglutide Reduce ... · The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE / and LDLr / Mice by a Mechanism That Includes

Novo Nordisk a focused healthcare company...Novo Nordisk® Diabetes: • Semaglutide 2.0 mg phase 3b trial successfully completed • Once-weekly insulin icodec phase 3 trial programme

Novo Nordisk a focused healthcare company...Novo Nordisk® Diabetes: • Semaglutide 2.0 mg phase 3b trial successfully completed • Once-weekly insulin icodec phase 3 trial programme

UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT … · 2019. 8. 6. · Version: 1.0 US (EN) Official name of the study: SELECT – Semaglutide effects on cardiovascular outcomes in people

UNIVERSITY OF PENNSYLVANIA RESEARCH SUBJECT … · 2019. 8. 6. · Version: 1.0 US (EN) Official name of the study: SELECT – Semaglutide effects on cardiovascular outcomes in people

Efficacy, Safety and Tolerability of Oral ... - Diabetes · Patients with type 2 diabetes uncontrolled on insulin, ± metformin, were randomized to oral semaglutide 3 mg (N=184),

Efficacy, Safety and Tolerability of Oral ... - Diabetes · Patients with type 2 diabetes uncontrolled on insulin, ± metformin, were randomized to oral semaglutide 3 mg (N=184),

A qos adaptive routing scheme (iglar) for highly dynamic

A qos adaptive routing scheme (iglar) for highly dynamic

VME Extension Handles - Pixus · PDF file133 Perfect Handling Solutions With VME64 Extension Handles Injector/extractor handle for insertion and removal of connectors with a large

VME Extension Handles - Pixus · PDF file133 Perfect Handling Solutions With VME64 Extension Handles Injector/extractor handle for insertion and removal of connectors with a large

Reference ID: 4190425including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1,

Reference ID: 4190425including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined (5.1,

Open access Research Comparative efficacy of once-weekly ... · Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one

Open access Research Comparative efficacy of once-weekly ... · Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one

Novo Nordisk WEGOVY- semaglutide injection, solution

Novo Nordisk WEGOVY- semaglutide injection, solution

MEMORIAL U0RAAY vwsmao, NJ. THE WESTFIELD LEADER · offensive Itoa *'fa. what; makes aw ruMang attack go." Dave TomatoMi, Dave Pryor, Rick Sampson, John Iglar and Jim HiWitiell along

MEMORIAL U0RAAY vwsmao, NJ. THE WESTFIELD LEADER · offensive Itoa *'fa. what; makes aw ruMang attack go." Dave TomatoMi, Dave Pryor, Rick Sampson, John Iglar and Jim HiWitiell along

Long-term efficacy and safety of oral semaglutide and the ...

Long-term efficacy and safety of oral semaglutide and the ...

The Sweetness of Pharmacotherapy · 2020. 8. 10. · CV Effects ASCVD: benefit in liraglutide>semaglutide>exenatide ER HF: Neutral Renal Dosing Progression of DKD: Benefit: liraglutide

The Sweetness of Pharmacotherapy · 2020. 8. 10. · CV Effects ASCVD: benefit in liraglutide>semaglutide>exenatide ER HF: Neutral Renal Dosing Progression of DKD: Benefit: liraglutide